Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
EVO
EVO
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
EVO News
Evotec Launches Strategic Transformation Initiative 'Horizon'
7h ago
Benzinga
U.S. Stocks Mixed in Morning Trading
11h ago
Benzinga
Zevra Therapeutics Reports Strong Q4 Earnings, Shares Surge
17h ago
Benzinga
DaVita Reports Strong Q4 Earnings, Shares Surge 21.7%
Feb 03 2026
Benzinga
Amgen Acquires Dark Blue Therapeutics for Up to $840 Million
Jan 07 2026
Benzinga
European Market Attracts Dividend Stock Investors Amid 17% Annual Return
Jan 06 2026
Yahoo Finance
NBI Revises EVO ETF Reinvested Distribution to $2.50 per Unit
Jan 05 2026
Yahoo Finance
Top European Dividend Stocks Analysis: Yields Exceeding 5%
Jan 02 2026
Yahoo Finance
Evotec Receives $5M Milestone Payment from Bristol Myers Following FDA Approval of New Drug Application
Nov 12 2025
SeekingAlpha
Evotec SE announces third quarter results
Nov 05 2025
SeekingAlpha
Sandoz to Purchase Just-Evotec Biologics EU SAS in Strategic Move to Expand Biosimilars Portfolio
Nov 05 2025
NASDAQ.COM
ESPR Seeks Diversification Through Rare Liver Disease Candidate, Shares Rise
Oct 17 2025
NASDAQ.COM
Evotec SE (EVO) Q2 2025 Earnings Call Transcript
Aug 13 2025
Newsfilter
Evotec SE reports 1H results
Aug 13 2025
SeekingAlpha
Evotec Accelerates Asset-Light Strategy With $300 Mln Biosimilars Deal To Sandoz
Jul 30 2025
NASDAQ.COM
Nasdaq Surges Over 100 Points; Domino's Shares Fall After Q2 Results
Jul 21 2025
Benzinga
Show More News
